Psilocybin lifts depression and anxiety in cancer patients, trials show
Psilocybin therapy took a remarkable step forward in 2016, when two clinical trials at Johns Hopkins and NYU found that a single guided session eased depression and anxiety in roughly 80% of cancer patients, with relief lasting at least six months. The results marked psychedelic research’s careful return to mainstream science after decades of dormancy.









